Difference between revisions of "Vasoactive intestinal peptide"
m |
|||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
− | |||
− | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 20: | Line 18: | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
− | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P01282 P01282 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
Line 26: | Line 24: | ||
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
− | | K21 | + | | K20, K21 |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
− | | TRLRK''Q'' | + | | TRLRK''Q''MAV''KK''YLNSI |
|- | |- | ||
| Structure | | Structure | ||
Line 41: | Line 39: | ||
|- | |- | ||
| Reference | | Reference | ||
− | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=12761400&dopt=Abstract PMID:12761400 ] |
|- | |- | ||
| Notes | | Notes | ||
| | | | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 12:01, 10 March 2015
Vasoactive intestinal peptide | |
---|---|
Substrate peptide name | Vasoactive intestinal peptide |
Synonyms | VIP |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular; Secreted |
Swissprot ID | P01282 |
Reactive glutamines | Q16 |
Reactive lysines | K20, K21 |
Substrate sequence | TRLRKQMAVKKYLNSI |
Structure | No available crystal structure |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:12761400 |
Notes | |